Skip to search formSkip to main contentSkip to account menu

Bladder tumor Ag

Known as: Bladder tumor Antigen 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
Transitional cell carcinoma of bladder (TCCB) is the most common malignancy of the genitourinary system. Despite the use of the… 
2004
2004
BackgroundBladder cancers have a high potential for recurrence and sometimes become invasive even in superficial cases. In this… 
2002
2002
OBJECTIVE To investigate a non-invasive, effective and rapid mode of detecting the recurrence of bladder cancer during follow-up… 
2001
2001
The purpose of this study is to evaluate the clinical usefulness of urinary nuclear matrix protein 22 (NMP22) as a marker for… 
2000
2000
OBJECTIVE To analyze the efficacy of the BTA Trak test as a diagnostic marker for bladder cancer, determine its correlation with… 
Review
1997
Review
1997
BACKGROUND: The incidence of bladder and prostate cancer continues to rise, with little accompanying improvement in management… 
1991
1991
Bladder tumor antigen (BTA) is a tumor marker isolated from the urine of individuals with TCC of the bladder. This antigen can be…